StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS)

StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued on Tuesday. The brokerage set a “hold” rating on the stock.

Milestone Scientific Price Performance

Shares of MLSS opened at $0.95 on Tuesday. Milestone Scientific has a 12-month low of $0.54 and a 12-month high of $1.39. The stock has a market capitalization of $74.18 million, a P/E ratio of -13.60 and a beta of 1.12. The firm’s 50 day moving average is $1.04 and its 200-day moving average is $0.96.

Institutional Investors Weigh In On Milestone Scientific

Several large investors have recently modified their holdings of the stock. Y Intercept Hong Kong Ltd acquired a new stake in shares of Milestone Scientific during the third quarter worth $48,000. Geode Capital Management LLC boosted its position in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares during the period. World Investment Advisors LLC purchased a new position in Milestone Scientific during the 3rd quarter valued at about $91,000. Carnegie Investment Counsel grew its position in Milestone Scientific by 18.9% during the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after purchasing an additional 27,412 shares in the last quarter. Finally, Renaissance Technologies LLC increased its stake in shares of Milestone Scientific by 72.8% in the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after acquiring an additional 53,198 shares during the last quarter. 5.79% of the stock is owned by institutional investors.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.